Achieve Optimal Health with Fleming Adult Health NP, PLLC
GLP-1 (Glucagon-like peptide-1) agonists are medications used to treat obesity and certain metabolic conditions. When it comes to guidelines related to BMI (Body Mass Index) for using GLP-1 agonists in obesity treatment, here are some general aspects:
💫 1. BMI Criteria: GLP-1 agonists may be considered for individuals with a BMI of 30 or higher or a BMI of 27 or higher with weight-related comorbidities (such as high blood pressure, high cholesterol or type 2 diabetes).
💫 2. Weight-Related Comorbidities: GLP-1 agonists are often prescribed for those with obesity and associated health issues, especially if other weight-loss methods have not been successful.
💫 3. Individualized Treatment: Your individual health conditions, medical history, and response to previous weight-loss attempts will be assessed before recommending GLP-1 agonists.
